Prognostic significance of positive peritoneal cytology in endometrial cancer patients

References

• Albertini A-F, Devouassoux-Shisheboran M, Genestie C. 2012. Pathology of endometrioid carcinoma. Bulletin du Cancer 99:7–12.
   PubMed Web of Science ®Google Scholar
• Bansal S, Buck AM, Herzog TJ, Deutsch I, Burke WM, Wright JD. 2009. Stage IIIA endometrial carcinoma: outcome and predictors of survival. Obstetrics and Gynecology 114:100–105.
   PubMed Web of Science ®Google Scholar
• Berretta R, Merisio C, Piantelli G, Rolla M, Giordano G, Melpignano M, Nardelli GB. 2008. Preoperative transvaginal ultrasonography and intraoperative gross examination for assessing myometrial invasion by endometrial cancer. Journal of Ultrasound in Medicine : official Journal of the American Institute of Ultrasound in Medicine 27:349–355.
   PubMed Web of Science ®Google Scholar
• Berretta R, Patrelli TS, Migliavacca C, Rolla M, Franchi L, Monica M, et al. 2014. Assessment of tumor size as a useful marker for the surgical staging of endometrial cancer. Oncology Reports 31:2407–2412.
   PubMed Web of Science ®Google Scholar
• Binesh F, Akhavan A, Behniafard N, Zabihi S, Hosseinizadeh E. 2014. Prognostic value of peritoneal washing cytology in gynecologic malignancies: a controversial issue. Asian Pacific Journal of Cancer Prevention 15:9405–9410.
   PubMedGoogle Scholar
• Cetinkaya K, Atalay F. 2015. Peritoneal cytology in endometrial cancer. Tumori Journal 101:697–700.
   PubMed Web of Science ®Google Scholar
• Elshaikh MA, Al-Wahab Z, Mahdi H, Albuquerque K, Mahan M, Kehoe SM, et al. 2015. Recurrence patterns and survival endpoints in women with stage II uterine endometrioid carcinoma: a multi-institution study. Gynecologic Oncology 136:235–239.
   PubMed Web of Science ®Google Scholar
• Fadare O, Mariappan MR, Hileeto D, Wang S, Mcalpine JN, Rimm DL. 2005. Upstaging based solely on positive peritoneal washing does not affect outcome in endometrial cancer. Modern Pathology 18:673–680.
   PubMed Web of Science ®Google Scholar
• Garg G, Gao F, Wright JD, Hagemann AR, Mutch DG, Powell MA. 2013. Positive peritoneal cytology is an independent risk-factor in early stage endometrial cancer. Gynecologic Oncology 128:77–82.
   PubMed Web of Science ®Google Scholar
• Garg G, Morris RT, Solomon L, Toy EP, Kruger M, Clary K, et al. 2011. Evaluating the significance of location of lymph node metastasis and extranodal disease in women with stage IIIC endometrial cancer. Gynecologic Oncology 123:208–213.
   PubMed Web of Science ®Google Scholar
• Grimshaw RN, Tupper WC, Fraser RC, Tompkins M, Jeffrey JF. 1990. Prognostic value of peritoneal cytology in endometrial carcinoma. Gynecologic Oncology 36:97–100.
   PubMed Web of Science ®Google Scholar
• Gu M, Shi W, Barakat RR, Thaler HT, Saigo PE. 2000. Peritoneal washings in endometrial carcinoma. A study of 298 patients with histopathologic correlation. Acta Cytologica 44:783–789.
   PubMed Web of Science ®Google Scholar
• Havrilesky LJ, Cragun JM, Calingaert B, Secord AA, Valea FA, Clarke-Pearson DL, et al. 2007. The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer. Gynecologic Oncology 104:401–405.
   PubMed Web of Science ®Google Scholar
• Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. 2008. Cancer statistics, 2008. CA: a Cancer Journal for Clinicians 58:71–96.
   PubMed Web of Science ®Google Scholar
• Kadar N, Homesley HD, Malfetano JH. 1994. Prognostic factors in surgical stage III and IV carcinoma of the endometrium. Obstetrics and Gynecology 84:983–986.
   PubMed Web of Science ®Google Scholar
• Kato R, Hasegawa K, Torii Y, Hirasawa Y, Udagawa Y, Fukasawa I. 2015. Cytological scoring and prognosis of poorly differentiated endometrioid adenocarcinoma. Acta Cytologica 59:83–90.
   PubMedGoogle Scholar
• Mclellan R, Dillon MB, Currie JL, Rosenshein NB. 1989. Peritoneal cytology in endometrial cancer: a review. Obstetrical & Gynecological Survey 44:711–719.
   PubMedGoogle Scholar
• Merisio C, Berretta R, De Ioris A, Pultrone DC, Rolla M, Giordano G, et al. 2005. Endometrial cancer in patients with preoperative diagnosis of atypical endometrial hyperplasia. European Journal of Obstetrics & Gynecology and Reproductive Biology 122:107–111.
   PubMed Web of Science ®Google Scholar
• Milgrom SA, Kollmeier M, Abu-Rustum N, Makker V, Gardner G, Barakat R, Alektiar K. 2013. Positive peritoneal cytology is highly predictive of prognosis and relapse patterns in stage III (FIGO 2009) endometrial cancer. Gynecologic Oncology 130:49–53.
   PubMed Web of Science ®Google Scholar
• Momayyezi M, Fallahzadeh H, Momayyezi M. 2015. Construction and validation the lifestyle questionnaire related to cancer. Iranian Journal of Cancer Prevention 8(5):e3965.
   PubMedGoogle Scholar
• Morrow CP, Bundy BN, Kurman RJ, Creasman WT, Heller P, Homesley HD, Graham JE. 1991. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecologic Oncology 40:55–65.
   PubMed Web of Science ®Google Scholar
• Nofech-Mozes S, Ackerman I, Ghorab Z, Ismiil N, Thomas G, Covens A, Khalifa MA. 2008. Lymphovascular invasion is a significant predictor for distant recurrence in patients with early-stage endometrial endometrioid adenocarcinoma. American Journal of Clinical Pathology 129:912–917.
   PubMed Web of Science ®Google Scholar
• Patrelli TS, Berretta R, Rolla M, Vandi F, Capobianco G, Gramellini D, et al. 2009. Pelvic lymphadenectomy in endometrial cancer: our current experience. European Journal of Gynaecological Oncology 30:536–538.
   PubMed Web of Science ®Google Scholar
• Pecorelli S. 2009. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics 105:103–104.
   PubMed Web of Science ®Google Scholar
• Preyer O, Obermair A, Formann E, Schmid W, Perrin LC, Ward BG, et al. 2002. The impact of positive peritoneal washings and serosal and adnexal involvement on survival in patients with stage IIIA uterine cancer. Gynecologic Oncology 86:269–273.
   PubMed Web of Science ®Google Scholar
• Ranjbar R, Nejatollahi F, Ahmadi ASN, Hafezi H, Safaie A. 2015. Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) in patients with serous ovarian carcinoma and their clinical significance. Iranian Journal of Cancer Prevention 8(4):e3428.
   PubMedGoogle Scholar
• Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. 2008. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. The Lancet 371:569–578.
   PubMed Web of Science ®Google Scholar
• Saga Y, Imai M, Jobo T, Kuramoto H, Takahashi K, Konno R, et al. 2006. Is peritoneal cytology a prognostic factor of endometrial cancer confined to the uterus? Gynecologic Oncology 103:277–280.
   PubMed Web of Science ®Google Scholar
• Siegel R, Ma J, Zou Z, Jemal A. 2014. Cancer statistics, 2014. CA: a Cancer Journal for Clinicians 64:9–29.
   PubMed Web of Science ®Google Scholar
• Soliman PT, Oh JC, Schmeler KM, Sun CC, Slomovitz BM, Gershenson DM, et al. 2005. Risk factors for young premenopausal women with endometrial cancer. Obstetrics and Gynecology 105:575–580.
   PubMed Web of Science ®Google Scholar
• Soliman PT, Wu D, Tortolero‐Luna G, Schmeler KM, Slomovitz BM, Bray MS, et al. 2006. Association between adiponectin, insulin resistance, and endometrial cancer. Cancer 106:2376–2381.
   PubMed Web of Science ®Google Scholar
• Takeshima N, Nishida H, Tabata T, Hirai Y, Hasumi K. 2001. Positive peritoneal cytology in endometrial cancer: enhancement of other prognostic indicators. Gynecologic Oncology 82:470–473.
   PubMed Web of Science ®Google Scholar
• Zhou B, Yang L, Sun Q, Cong R, Gu H, Tang N, et al. 2008. Cigarette smoking and the risk of endometrial cancer: a meta-analysis. The American Journal of Medicine 121:501–508. e3.
   PubMed Web of Science ®Google Scholar